Xiong L - Search Results

1

High expression of IL-4R enhances proliferation and invasion of hepatocellular carcinoma cells.

Guo C, Ouyang Y, Cai J, Xiong L, Chen Y, Zeng X, Liu A. Guo C, et al. Among authors: xiong l. Int J Biol Markers. 2017 Oct 31;32(4):e384-e390. doi: 10.5301/ijbm.5000280. Int J Biol Markers. 2017. PMID: 28665449 Free article.

2

Clinicopathologic characteristics and prognostic factors for primary spinal epidural lymphoma: report on 36 Chinese patients and review of the literature.

Xiong L, Liao LM, Ding JW, Zhang ZL, Liu AW, Huang L. Xiong L, et al. BMC Cancer. 2017 Feb 14;17(1):131. doi: 10.1186/s12885-017-3093-z. BMC Cancer. 2017. PMID: 28196505 Free PMC article. Review.

3

USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway.

Cai J, Liu T, Huang P, Yan W, Guo C, Xiong L, Liu A. Cai J, et al. Among authors: xiong l. Biochem Biophys Res Commun. 2017 Apr 22;486(1):184-190. doi: 10.1016/j.bbrc.2017.03.025. Epub 2017 Mar 9. Biochem Biophys Res Commun. 2017. PMID: 28286270

4

Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.

Xiong L, Zeng XL, Guo CK, Liu AW, Huang L. Xiong L, et al. BMC Cancer. 2017 Apr 11;17(1):254. doi: 10.1186/s12885-017-3247-z. BMC Cancer. 2017. PMID: 28399835 Free PMC article.

5

BRCA1 protects cardiac microvascular endothelial cells against irradiation by regulating p21-mediated cell cycle arrest.

Zeng ZM, Du HY, Xiong L, Zeng XL, Zhang P, Cai J, Huang L, Liu AW. Zeng ZM, et al. Among authors: xiong l. Life Sci. 2020 Mar 1;244:117342. doi: 10.1016/j.lfs.2020.117342. Epub 2020 Jan 21. Life Sci. 2020. PMID: 31978450

6

Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer.

Yi Y, Cai J, Xu P, Xiong L, Lu Z, Zeng Z, Liu A. Yi Y, et al. Among authors: xiong l. J Transl Med. 2022 Mar 14;20(1):122. doi: 10.1186/s12967-022-03331-9. J Transl Med. 2022. PMID: 35287683 Free PMC article.

7

Correction: Potential benefit of osimertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer.

Yi Y, Cai J, Xu P, Xiong L, Lu Z, Zeng Z, Liu A. Yi Y, et al. Among authors: xiong l. J Transl Med. 2022 Jun 27;20(1):292. doi: 10.1186/s12967-022-03453-0. J Transl Med. 2022. PMID: 35761407 Free PMC article. No abstract available.

8

Oncostatin M/Oncostatin M Receptor Signal Induces Radiation-Induced Heart Fibrosis by Regulating SMAD4 in Fibroblast.

Xu P, Yi Y, Xiong L, Luo Y, Xie C, Luo D, Zeng Z, Liu A. Xu P, et al. Among authors: xiong l. Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):203-217. doi: 10.1016/j.ijrobp.2023.07.033. Epub 2023 Aug 23. Int J Radiat Oncol Biol Phys. 2024. PMID: 37610394 Free article.

9

Non-small cell lung cancer cells with uncommon EGFR exon 19delins variants respond poorly to third-generation EGFR inhibitors.

Lu Z, Yi Y, Wang L, Luo Y, Luo D, Xiong L, Shu Y, Luo H, Li J, Zhu W, Zeng Z, Liu A. Lu Z, et al. Among authors: xiong l. Transl Oncol. 2024 Jan;39:101834. doi: 10.1016/j.tranon.2023.101834. Epub 2023 Nov 24. Transl Oncol. 2024. PMID: 38006760 Free PMC article.

10

Comparison of clinical outcomes in patients with advanced pulmonary sarcomatoid carcinoma treated with immunotherapy-based regimens or chemotherapy: A study based on the SEER database and multicentric real-world settings.

Peng D, Xiong L, Luo Y, Chen J, Zheng Y, Zeng X, Liu S, Liu A, Wang X, Zeng Z. Peng D, et al. Among authors: xiong l. J Cancer Res Ther. 2024 Dec 1;20(7):2110-2117. doi: 10.4103/jcrt.jcrt_479_24. Epub 2025 Jan 10. J Cancer Res Ther. 2024. PMID: 39792422 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,536 results

Search Page

Filters